Table 2.
Estimated Changes in Weight, Body Fat, Percent Body Fat, Central-to-Peripheral Fat Ratio, and Total Body Lean Mass across 36 Months by Contraceptive Methoda,b,c
OC | DMPA | NH | P value* | |
---|---|---|---|---|
Weight, kg |
NH vs. OC: = .168 NH vs DMPA: <.001 OC vs. DMPA: <.002 |
|||
6 mo | −1.17 | 1.48 | 0.19 | |
12 mo | −0.35 | 1.93 | 0.86 | |
18 mo | 0.07 | 4.43 | 1.37 | |
24 mo | −0.08 | 4.44 | 0.07 | |
30 mo | 0.65 | 4.87 | 1.62 | |
36 mo | 1.47 | 5.12 | 2.05 | |
Total body fat, kg |
NH vs. OC: <.01 NH vs DMPA: <.001 OC vs. DMPA: <.001 |
|||
6 mo | −0.56 | 1.17 | −0.05 | |
12 mo | 0.15 | 1.78 | 0.09 | |
18 mo | 0.59 | 3.63 | 0.30 | |
24 mo | 0.67 | 3.72 | −0.37 | |
30 mo | 1.20 | 3.87 | 0.91 | |
36 mo | 1.90 | 4.14 | 1.17 | |
Percent body fat, % |
NH vs. OC: <.01 NH vs DMPA: <.001 OC vs. DMPA: <.003 |
|||
6 mo | 0.02 | 1.07 | −0.23 | |
12 mo | 0.72 | 1.75 | −0.31 | |
18 mo | 1.14 | 3.02 | −0.31 | |
24 mo | 1.26 | 3.16 | −0.44 | |
30 mo | 1.38 | 3.27 | 0.42 | |
36 mo | 1.63 | 3.41 | 0.51 | |
Central-to-peripheral fat ratio |
NH vs. OC: = .135 NH vs DMPA: <.001 OC vs. DMPA: <.001 |
|||
6 mo | −0.01 | 0.03 | −0.01 | |
12 mo | −0.02 | 0.05 | −0.01 | |
18 mo | −0.02 | 0.08 | −0.02 | |
24 mo | −0.01 | 0.09 | −0.03 | |
30 mo | 0.00 | 0.10 | −0.03 | |
36 mo | 0.00 | 0.10 | 0.00 | |
Total body lean mass | NH vs. OC: <.026 NH vs DMPA: =.996 OC vs. DMPA: <.016 |
|||
6 mo | −0.89 | 0.30 | 0.25 | |
12 mo | −0.77 | 0.01 | 0.63 | |
18 mo | −0.92 | 0.50 | 0.67 | |
24 mo | −1.15 | 0.44 | −0.39 | |
30 mo | −0.78 | 1.00 | 0.17 | |
36 mo | −0.36 | 1.16 | −0.24 |
OC = oral contraceptive; DMPA = depot medroxyprogesterone acetate; NH = nonhormonal contraception.
Mean baseline value was subtracted from mean modeled value at each follow-up visit to generate the numbers in the table.
Adjusted by baseline values (baseline weight, total body fat, percent body fat, or baseline central-to-peripheral fat ratio), age (16–24 years vs. 25–33 years), age at menarche (years in continuous scale), race/ethnicity (black, white, and Hispanic), parity, weight-bearing exercise (≤120min/wk vs. >120min/wk), alcohol use (gm/day), smoking status (current smoker vs. not), months of pill use, and previous use of DMPA.
Linear mixed model was used for the adjustment, and P values are based on the main effect models.
P values indicate the difference between the methods across 36 months.